99% CYCLOPHOSPHAMIDE AND ITS RELATED COMPOUNDS, Analytical Grade, 25mg

CYCLOPHOSPHAMIDE AND IT’S RELATED COMPOUNDS
 
1. Cyclophosphamide RC-D Mono Ethyl Ester

A monoethyl ester derivative of Cyclophosphamide.

Likely used as a reference compound (RC) in impurity profiling or stability studies.

2. Cyclophosphamide RC-B Ethyl Ester

An ethyl ester variant categorized under RC-B.

Possibly formed as a degradation product or synthesis intermediate.

3. Cyclophosphamide RC-C Monethyl Ester: 3-Aminopropyl Ethyl Hydrogen Phosphate

Contains a 3-aminopropyl group with an ethyl hydrogen phosphate moiety.

Categorized under RC-C, indicating a related compound or process impurity.

4. Cyclophosphamide RC-C: 3-Aminopropyl Diethyl Phosphate

Similar to the above but with diethyl phosphate instead of ethyl hydrogen phosphate.

Suggests slight variation in esterification.

5. Cyclophosphamide Related Compound B

CAS: 158401-52-6

Registered compound, indicating known structure and properties.

Used for impurity profiling or analytical standards.

6. Cyclophosphamide Related Compound C

No specific structure or CAS provided.

Likely another known impurity or degradation product, tracked in pharmaceutical formulations.

7. Cyclophosphamide Related Compound D

CAS: 158401-51-5

Includes a chloroethyl side chain based on the partial structure visible.

Another known impurity, likely resulting from cyclophosphamide's decomposition or synthesis route.

8. Cyclophosphamide Related Compound F

Name: 2-((2-chloroethyl)(2-ethoxyethyl)amino)-1,3,2-oxazaphosphinane 2-oxide

CAS: 2387771-96-0

OR referred to as Compound F.

Structurally related to cyclophosphamide with substitutions on the nitrogen side chains.

9. Ethyl (3-(piperazin-1-yl)propyl) Hydrogen Phosphate

CAS: 2387771-94-8

Likely a derivative or impurity with a piperazine ring.

May arise in synthetic or degradation processes.

10. N-Nitroso Cyclophosphamide (Hydrate)

A nitrosated form of Cyclophosphamide.

Known for potential carcinogenicity and is a toxic impurity.

Requires careful monitoring in drug manufacturing.